FOUNTAIN VALLEY, CALIFORNIA--(MARKET WIRE)--Sep 6, 2007 -- Sutura, Inc. ("Sutura") (OTC BB:SUTU.OB - News), an innovative developer of minimally invasive vascular suturing devices, today announced that the first patient to receive a SuperStitch EL to close her Patent Foramen Ovale (PFO) has been discharged from hospital. Dr. Nicholas Kipshidze, Physician in Chief and General Director of the Central University Hospital in Tblisi, Georgia and Director of Preclinical Research, Lennox Hill Hospital in New York, who along with Dr. Irakli Gogorishvili performed the first human case with Drs. Carlos Ruiz and Michael Mullen, announced that the 18-year-old patient was discharged the day after the procedure and was able to celebrate her 19th birthday at home having had her PFO successfully closed with the Supersitch EL.
